10-124789134-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_212554.4(EEF1AKMT2):c.200G>A(p.Arg67Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000156 in 1,612,708 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00016 ( 1 hom. )
Consequence
EEF1AKMT2
NM_212554.4 missense
NM_212554.4 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 6.71
Genes affected
EEF1AKMT2 (HGNC:33787): (EEF1A lysine methyltransferase 2) Enables protein-lysine N-methyltransferase activity. Involved in peptidyl-lysine methylation. Located in cytosol and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EEF1AKMT2 | NM_212554.4 | c.200G>A | p.Arg67Gln | missense_variant | 3/7 | ENST00000368836.7 | |
EEF1AKMT2 | NM_001416243.1 | c.200G>A | p.Arg67Gln | missense_variant | 3/6 | ||
EEF1AKMT2 | NM_001304467.2 | c.-39G>A | 5_prime_UTR_variant | 3/7 | |||
EEF1AKMT2 | NM_001304468.2 | c.-39G>A | 5_prime_UTR_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EEF1AKMT2 | ENST00000368836.7 | c.200G>A | p.Arg67Gln | missense_variant | 3/7 | 1 | NM_212554.4 | ||
EEF1AKMT2 | ENST00000464099.5 | c.200G>A | p.Arg67Gln | missense_variant, NMD_transcript_variant | 3/6 | 1 | |||
EEF1AKMT2 | ENST00000466270.5 | c.200G>A | p.Arg67Gln | missense_variant, NMD_transcript_variant | 3/7 | 1 | |||
EEF1AKMT2 | ENST00000652548.2 | c.200G>A | p.Arg67Gln | missense_variant | 3/6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152126Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
12
AN:
152126
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000219 AC: 55AN: 250916Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135616
GnomAD3 exomes
AF:
AC:
55
AN:
250916
Hom.:
AF XY:
AC XY:
30
AN XY:
135616
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000164 AC: 239AN: 1460582Hom.: 1 Cov.: 29 AF XY: 0.000171 AC XY: 124AN XY: 726654
GnomAD4 exome
AF:
AC:
239
AN:
1460582
Hom.:
Cov.:
29
AF XY:
AC XY:
124
AN XY:
726654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152126Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74320
GnomAD4 genome
AF:
AC:
12
AN:
152126
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
44
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.200G>A (p.R67Q) alteration is located in exon 3 (coding exon 3) of the METTL10 gene. This alteration results from a G to A substitution at nucleotide position 200, causing the arginine (R) at amino acid position 67 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at